AstraZeneca & Pangaea Partner to Advance AI-Powered Precision Healthcare

Microsoft & NVIDIA Documentary: Pangaea Data Closing Care Gaps

Pangaea Data enters AI collaboration with Alexion to help improve detection of HPP in adults

Pangaea Data Secures Strategic Investment from Topcon Healthcare to Close Care Gaps in Eye Care

GO BACK

Discovery of 6x More Undiagnosed & Miscoded COPD & At-risk CKD Patients

10:00 - 11:20AM BST, April 24th 2024, HealthTech R&D Spotlight, London, UK

Session & Track: HealthTech R&D Spotlight, Science Track 2

Venue: Convene, 133 Houndsditch, London, UK

Learn how Pangaea’s product applies AI based on clinical guidelines to help clinicians find and connect to more untreated patients as part of their usual workflows, without disruption, and enables financially sustainable, scalable, privacy-preserving collaborations between healthcare providers and pharmacueticals. For example, sponsored by a global pharmaceutical, Pangaea’s product was applied to find 6x more undiagnosed and miscoded COPD and at-risk CKD patients, compared to if ICD codes were used. This work is now being scaled across healthcare providers in the USA, Spain and Japan.

Please let us know if you are available to meet by registering through the form below or emailing us at info@pangaeadata.ai

Register to Meet Us

Presenter

Dr. Vibhor Gupta
Founder
Pangaea Data